CIBC World Market
ENTA icon

CIBC World Market’s Enanta Pharmaceuticals ENTA Stock Holding History

CIBC World Market’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,727
Closed -$108K – 1381
2024
Q4 		$108K Buy
+18,727
New +$180K ﹤0.01% 1315
2018
Q3 		– Sell
-22,391
Closed -$2.6M – 1152
2018
Q2 		$2.6M Buy
22,391
+18,293
+446% +$1.83M 0.01% 417
2018
Q1 		$332K Buy
+4,098
New +$315K ﹤0.01% 964
2015
Q1 		– Sell
-4,177
Closed -$212K – 843
2014
Q4 		$212K Buy
+4,177
New +$187K ﹤0.01% 750

Other funds holding ENTA

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC World Market's ENTA Position: Q1 2025 in Review

CIBC World Market sold out of Enanta Pharmaceuticals (ENTA) in Q1 2025, closing a stake of 18,727 shares — an estimated $108K sold.

CIBC World Market first reported a position in ENTA in Q4 2014 and held it in 4 quarters. The position peaked at $2.6M in Q2 2018. 109 funds tracked by Wall St. Rank hold ENTA as of Q1 2025.

  • CIBC World Market reported no remaining Enanta Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • CIBC World Market sold 18,727 Enanta Pharmaceuticals shares in Q1 2025, an estimated $108K.
  • CIBC World Market first reported a position in Enanta Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • CIBC World Market's Enanta Pharmaceuticals position peaked at $2.6M in Q2 2018.
  • 109 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2025.

Based on CIBC World Market's 13F filing for Q1 2025, filed 14 May 2025.